Gene Promoter-Methylation Signature as Biomarker to Predict Cisplatin-Radiotherapy Sensitivity in Locally Advanced Cervical Cancer

Despite efforts to promote health policies focused on screening and early detection, cervical cancer continues to be one of the leading causes of mortality in women; in 2020, estimated 30,000 deaths in Latin America were reported for this type of tumor. While the therapies used to treat cervical can...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras-Romero, Carlos, Pérez-Yépez, Eloy-Andrés, Martinez-Gutierrez, Antonio Daniel, Campos-Parra, Alma, Zentella-Dehesa, Alejandro, Jacobo-Herrera, Nadia, López-Camarillo, César, Corredor-Alonso, Guillermo, Martínez-Coronel, Jaime, Rodríguez-Dorantes, Mauricio, de León, David Cantu, Pérez-Plasencia, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963763/
https://www.ncbi.nlm.nih.gov/pubmed/35359376
http://dx.doi.org/10.3389/fonc.2022.773438

Ejemplares similares

Ejemplares similares